Alpha Cognition (ACOG) Non Operating Income (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Non Operating Income of $725604.0 for Q4 2025, up 123.27% year-over-year from $324993.8 in Q4 2024, and down 81.83% quarter-over-quarter from $4.0 million in Q3 2025.
Alpha Cognition (ACOG) Non Operating Income (2023 - 2026) Analysis & Trends
Alpha Cognition's Non Operating Income history runs 3 years deep, the most recent figure standing at $725604.0 for Q4 2025.
- In Q4 2025, Non Operating Income rose 123.27% year-over-year to $725604.0; the TTM figure through Dec 2025 stood at $1.6 million (up 159.34% YoY), while the FY2025 annual figure was $2.0 million, up 171.71% from the prior year.
- Non Operating Income for Q4 2025 stood at $725604.0, down from $4.0 million in the prior quarter.
- The five-year high for Non Operating Income was $4.0 million in Q3 2025, with the low at -$4.8 million in Q2 2025.
- The 3-year median for Non Operating Income is -$89516.0 (2023), against an average of -$457712.1.
- Peak annual rise in Non Operating Income reached 536.1% in 2025, while the deepest fall reached 1654.45% in 2025.
- Alpha Cognition's Non Operating Income stood at -$3.3 million in 2023, then grew by 5.88% to -$3.1 million in 2024, then surged by 123.27% to $725604.0 in 2025.
- Business Quant data shows ACOG's Non Operating Income at $725604.0 in Q4 2025, $4.0 million in Q3 2025, and -$4.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | -1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.03 Mn |
| Dec 31, 2025 | 725,604.00 |
| Sep 30, 2025 | 3.99 Mn |
| Jun 30, 2025 | -4.75 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | -3.12 Mn |
| Sep 30, 2024 | 627,878.00 |
| Jun 30, 2024 | 305,699.00 |
| Mar 31, 2024 | -591,193.00 |
| Dec 31, 2023 | -3.31 Mn |
| Sep 30, 2023 | -503,210.00 |
| Jun 30, 2023 | -89,516.00 |